Writing up the research noteFirst read for a new ticker takes about 20-30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2028 revenue reaching $158M — +14.6% growth in a single year.
What Moves the Stock
01Design-win announcements with major OEMs in industrial automation, medical devices, or smart city projects - these signal future revenue streams 12-24 months out
02Quarterly revenue guidance and bookings trends - market is hypersensitive to stabilization signals given -23% YoY decline
03Gross margin trajectory - ability to maintain 40%+ margins while competing against lower-cost Asian competitors
04Operating expense management and path to profitability - cash burn rate and runway given minimal free cash flow
05Industrial capex trends and IoT adoption rates in target verticals (manufacturing, transportation, healthcare)
06IoT embedded modules and system-on-modules (estimated 40-50% of revenue) - sold to OEMs for integration into industrial equipment, medical devices, and transportation systems
07IoT gateways and edge computing devices (estimated 30-40%) - protocol converters and edge intelligence hardware for industrial automation and smart infrastructure
08Software subscriptions and device management services (estimated 10-20%) - recurring revenue from ConsoleFlow and other cloud-based management platforms
momentum/turnaround - The 87% 1-year return despite deteriorating fundamentals suggests speculative interest from traders betting on revenue…
Moderate sensitivity through two channels: (1) Higher rates reduce customer capex budgets for IoT infrastructure projects…
Watch on earnings: ISM Manufacturing PMI (INDPRO proxy) - leading indicator of industrial capex spending and OEM production activity, Industrial production index - directly correlates with demand for factory automation and IoT connectivity solutions, Federal funds rate and 10-year Treasury yield - impact customer project financing costs and Lantronix's valuation multiple.
One Sentence Summary:
Lantronix: the story is balanced — design-win announcements with major oems in industrial automation, medical devices.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
